AM-Pharma's Series E Round

AM-Pharma raised a round of funding on September 11, 2014.

AM-Pharma is a biopharmaceutical company focused on the pre-clinical and clinical development of Alkaline Phosphatase to treat severe conditions where inflammation plays an important role. The product…

Articles about AM-Pharma's Series E Round: